Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 clinical trial evaluating the safety, pharmacokinetics, and pharmacodynamics of UCB4940 in patients with mild t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• UCB4940

Snippet

Sponsor: UCB Celltech | Conditions: Mild to Moderate Psoriasis | Phase 1 | Status: COMPLETED